Given the impressive advances in therapies across a host of conditions, these were astonishing confessions but reflected a general malaise with accepting the status quo instead of ‘rocking all over the world’.

It has, perhaps, taken the digital era, AI disruption and a COVID-shaped existential crisis for our industry to fully comprehend its own potential. This three-pronged fork to the backside has sent us all cartwheeling into a future we could not have envisaged.

There are countless examples in pop culture of people who, at the top their game, should have headed for a breathtakingly high summit but instead chose to defy their own promise, while settling onto the bar stool of ‘what might have been’.

At his peak, George Best went to play for Hibernian, Damien Hirst stopped making interesting statements about art/economics in order to focus purely on economics and Orson Welles voiced the character of Optimus Prime in the Transformers television series. They must serve as a warning!

Indeed, we must use the three-pronged fork – the will to win within – to change gear and become navigators in flight; zig-zagging the admittedly annoying regulatory terrain, super-charging R&D, igniting R&D and futurising clinical trials.

Pharma has a chance to shape its destiny – to be ‘prime pharma’.

Enjoy the mag,

John Pinching
editor

PharmaTimes Media Ltd,
44 Maiden Lane
Covent Garden
London
WC2E 7LN
Tel: +44 (0)20 7240 6999
www.pharmatimes.com Twitter: @PharmaTimes

EDITORIAL
John Pinching / editor
john.pinching@pharmatimes.com

Iona Everson / group managing editor
iona.everson@pharmatimes.com

Karl Equi / executive director
karl.equi@pharmatimes.com  

SALES & MARKETING
Tara Lovegrove / business director
tara.lovegrove@pharmatimes.com

Luci Sargood / business manager
luci.sargood@pharmatimes.com

SUBSCRIPTIONS/REPRINTS
Digital and paper copies available free to qualifying readers: www.pharmatimes.com/subscribe
Tel: 01372 414 222
subscriptions@pharmatimes.com
Paper subscriptions available at £90.00 UK and £100.00 overseas per annum.

Views expressed by the contributors do not necessarily represent those of the publisher, editor or staff.

Material may not be reproduced in any form without the publisher’s written permission. © Copyright 2025 PharmaTimes Magazine. All rights reserved. PharmaTimes Magazine is published by PharmaTimes Media Ltd, which is registered as a limited company in England; No 09019637.